We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > CHF

News List

NBE Therapeutics Closes a CHF 20 Million Financing by Novo Holdings A/S b3cnewswire
July 04, 2018
NBE Therapeutics AG, a biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for improved cancer therapy, today announces a CHF 20 million extension of the Series B round. Together with an earlier CHF 20 million series B fin
Which is to dominate the future heart failure drug market?(2) en-cphi.cn
October 27, 2017
Sales of Entresto® rising steadily upon the Class I recommendation by the European and American heart failure guideline...
Which is to dominate the future heart failure drug market?(1) en-cphi.cn
October 26, 2017
An incident happened to the representative heart disease products with TCM characteristics several days ago, which attracted broad attention of the industry.